# Zhujiang Hospital

Organization · id `cardio:org-zhujiang-hospital` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ROR record 02mhxa927](<https://ror.org/02mhxa927>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 6 trials in this atlas.

## Technical summary

Sponsor class other. Matched to ROR record 02mhxa927 by an exact name.

## The registry's words

- Sponsor name: Zhujiang Hospital
- Sponsor class: OTHER
- ROR name: Zhujiang Hospital

## Connected pages

- Sponsors: Rituximab Combined With MSCs in the Treatment of PNS (3-4 Stage of CKD) (`cardio:ct-nct02966717`)
- Sponsors: Study of Efficacy, Weight Control, and Safety in Newly-diagnosed Type 2 Diabetes With Different Antidiabetic Therapy (`cardio:ct-nct03700801`)
- Sponsors: Interleukin-6 Receptor Inhibition for Symptomatic Intracranial Atherosclerosis (`cardio:ct-nct06447701`)
- Sponsors: Effect of Henagliflozein on Hepatic Fat Content in Patients With T2DM and NAFLD (`cardio:ct-nct06449833`)
- Sponsors: Surface-Modified Flow Diverter for Intracranial Aneurysms: Assessment of Ischemic and Clinical Outcomes (`cardio:ct-nct07674004`)
- Sponsors: Study on the Safety and Efficacy of a Time-of-Day-Based Individualized Tacrolimus Dosing Regimen in Kidney Transplant Recipients (`cardio:ct-nct07877103`)

## Provenance

Content hash: 1cedbe7a09740a59a96636a7057f250681725a7fa8593c561621849a41f5c412
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
